Nektar Therapeutics (NKTR)
54.70
+3.58
(+7.00%)
USD |
NASDAQ |
Dec 12, 16:00
55.20
+0.50
(+0.91%)
After-Hours: 20:00
Nektar Therapeutics Gross Profit (Quarterly): 11.59M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Amgen, Inc. | 6.503B |
| Amicus Therapeutics, Inc. | 147.72M |
| Eli Lilly & Co. | 14.59B |
| Rigel Pharmaceuticals, Inc. | 64.71M |
| Zevra Therapeutics, Inc. | 24.51M |